PHA Classroom: e-Learning. Anytime. Anyplace.

>> Back to Recordings
 
Session Recording from 2011
PHA on the Road, Minneapolis

What Is on the Horizon for PAH? (Clinical Trials)

June 18, 2011

Clinical trials in PAH have led to FDA approval of nine therapies over the past 13 years! This presentation will highlight the various clinical trials that are currently active and briefly discuss the trials that have recently been completed.

View the recording (recording will open in a new window)

Presenter Information

Michael D. McGoon, MD, Mayo Clinic, Rochester, Minn.
 
 

>>If you liked this recording, you may enjoy PIM-1: A New Hope for the Diagnosis and Treatment of PH

PIM-1: A New Hope for the Diagnosis and Treatment of PH

DIAMOND
SUPPORTER

PLATINUM
SUPPORTER

GOLD
SUPPORTER

SILVER
SUPPORTER

Actelion Pharmaceuticals US, Inc. Gilead Sciences, Inc. United Therapeutics Corporation Bayer HealthCare
This is a program of the PHA Medical Education Fund, made possible through unrestricted educational grants from our supporters.

 

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

For the best viewing experience of this site, it is recommended that you use Internet Explorer 8 or 9 or Firefox.

© 2014 Pulmonary Hypertension Association. All Rights Reserved.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
Webmaster@PHAssociation.org
    Privacy Policy   Virtual Tour of Website    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.®

NORD

The National Organization for Rare Disorders (NORD) awarded PHA the Abbey S. Meyers Leadership Award in 2012 for outstanding service to PHA members in advocacy, education and other key areas.